Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single ascending dose study of LYS006 in healthy Japanese male participants
jRCT2051200111Phase 1Completed
- Sponsor
- Novartis
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in None comparing LYS006 with Placebo (2 arms). Primary endpoint: Safety. Started Jan 2021; status: completed.
02
Drugs
LYS006
Beyond the preview
Go deeper on jRCT2051200111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051200111.